Unity Biotechnology - Raised $206M Funding from 23 investors

Aug 17, 2021 · Unity Biotechnology has raised a total funding of $206M over 5 rounds from 23 investors. Investors include Hercules Capital, Venrock and 21 others. Their latest funding …

CouponFollow Extension

$206
OFF

Unity Biotechnology - Raised $206M Funding From 23 Investors

5 days from now

Aug 17, 2021 · Unity Biotechnology has raised a total funding of $206M over 5 rounds from 23 investors. Investors include Hercules Capital, Venrock and 21 others. Their latest funding …

tracxn.com

$29
OFF

UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial …

5 days from now

Nov 13, 2023 · Cash used in operations during the nine quarters of 2023 was $29.5 million compared to $40.7 million for the nine quarters of 2022. Research and development expenses …

yahoo.com

FAQs about Unity Biotechnology - Raised $206M Funding from 23 investors Coupon?

How much money has Unity Biotechnology raised?

UNITY Biotechnology has raised a total of $290.6M in funding over 7 rounds. Their latest funding was raised on Aug 4, 2020 from a Post-IPO Debt round. UNITY Biotechnology is registered under the ticker NASDAQ:UBX . Their stock opened with $17.00 in its May 2, 2018 IPO. UNITY Biotechnology is funded by 24 investors. ...

What did Unity Biotechnology do in the second quarter 2023?

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2023. ...

Does Unity Biotechnology have an IPO?

Their stock opened with $17.00 in its May 2, 2018 IPO. UNITY Biotechnology is funded by 24 investors. Hercules Capital and Invus are the most recent investors. UNITY Biotechnology has raised a total of $290.6M in funding over 7 rounds. Their latest funding was raised on Aug 4, 2020 from a Post-IPO Debt round. ...

How much money will unity invest in 2023?

Cash, cash equivalents and marketable securities totaled $71.0 million as of June 30, 2023 compared with $94.8 million as of December 31, 2022. UNITY believes that current cash, cash equivalents and marketable securities are sufficient to fund operations into the fourth quarter of 2024. ...

What is Unity Biotechnology?

UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn. ...

How much cash was used in operations in 2023?

Cash used in operations during the first and second quarters of 2023 was $22.4 million compared to $29.8 million for the first and second quarters of 2022. Research and development expenses decreased by $1.1 million, to $6.5 million for the three months ended June 30, 2023 from $7.6 million for the three months ended June 30, 2022. ...